Keyphrases
Brain Tumor
100%
Interleukin-2
100%
Paracrine
100%
Local Chemotherapy
100%
Tumor Cells
28%
Inflammatory Response
28%
Biodegradable Polymers
28%
Combination Treatment
28%
Tissue Necrosis
28%
Intracranial Delivery
28%
1,3-bis(2-chloroethyl)-1-nitrosourea
28%
Clinical Trials
14%
Chemotherapy
14%
Immune Response
14%
Inflammation
14%
Treatment Strategy
14%
Tumor
14%
Median Survival
14%
Combination Therapy
14%
Primary Brain Tumor
14%
Genetic Engineering
14%
Improved Survival
14%
Local Delivery
14%
Histopathological Examination
14%
Day 14
14%
Carboplatin
14%
Antineoplastic Drugs
14%
Model Trial
14%
Intracranial Tumor
14%
Combined Treatment
14%
Long-term Survivors
14%
Carmustine
14%
Non-replicating
14%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Experimental Brain Tumor
100%
Immunotherapy
100%
Interleukin 2
100%
Carmustine
42%
Neoplasm
42%
Inflammation
42%
Intracranial Tumor
28%
Tissue Necrosis
28%
Murine
14%
Clinical Trial
14%
Anticarcinogen
14%
Brain Cancer
14%
Combination Therapy
14%
Carboplatin
14%
Neuroscience
Interleukin 2
100%
Immunotherapy
100%
Intracranial Tumor
100%
Nitrosourea
28%
Necrosis
28%
Carboplatin
14%
Carmustine
14%
Antineoplastic Drugs
14%
Veterinary Science and Veterinary Medicine
Protocerebrum
100%
Mouse
25%